What techniques will be in the toolbox 10 years from now? We speak to academic and industry experts to find out.

Phyllis Greenberger, President and CEO of the Society for Women’s Health Research (SWHR).

Glycan analysis poses major challenges for the biopharma industry; how can new technology lighten the load?

The potential for growth is huge, but how do you break into the market?

No-one likes getting injections. Fortunately, patients may soon have a pain-free alternative in the form of microneedle delivery systems.

The latest devices can deliver a drug in the right place and at the right time at the push of a button.

The first US biosimilar has been pocketed and the game is on. We bring six experts to the table to discuss the impact on industry dynamics.

The industry has been dipping its toe into the water of continuous manufacturing for years.

Without proper supply chain management, efforts to supply drugs to the developing world are wasted.

Legislation on pediatric medicines is sowing the seeds for a better future, but we must maintain momentum if children are to get the best possible care.